Department of Pharmacology, University College London, London WC1E 6BT, UK
Mini Review
A Clinical Report on the Safety and Successful Application of Tocilizumab in Rheumatoid Arthritis Patients Receiving Continuous Haemodialysis Treatment
Author(s): Daniel Mikos*
Rheumatoid Arthritis (RA) is a chronic autoimmune disorder characterized by joint inflammation and damage. Tocilizumab, an interleukin-6
receptor inhibitor, has emerged as a promising treatment for RA. However, concerns exist about its safety and effectiveness in patients undergoing
continuous haemodialysis treatment. This clinical report presents a comprehensive analysis of the safety and successful application of Tocilizumab
in RA patients on continuous haemodialysis... Read More»
DOI:
10.37421/2952-8100.2023.6.429
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 